膀胱副神經節瘤合併術中高血壓:病例報告及文獻回顧

張廷旭1

戴德森醫療財團法人嘉義基督教醫院 泌尿科

Bladder paraganglioma with Intraoperative Hypertensive Crisis: A Case report and literature review

Jeong Uk Jang1

Department of Urology1, Ditmanson Medical Foundation Chiayi Christian Hospital, Chia-Yi, Taiwan

 

Abstract:

Bladder paraganglioma is a rare neuroendocrine tumor arising from chromaffin cells and accounts for less than 0.05% of all bladder tumors. Clinical presentation varies from asymptomatic hematuria to catecholamine-related symptoms such as hypertension and palpitations. We report a 59-year-old man presenting with intermittent painless hematuria. Imaging revealed a bladder mass, and cystoscopy demonstrated a submucosal tumor. The patient underwent transurethral resection of bladder tumor (TURBT), during which a hypertensive crisis occurred. Histopathological examination confirmed paraganglioma with typical Zellballen architecture and positive immunohistochemical staining for synaptophysin and chromogranin. Bladder paraganglioma should be considered in patients with submucosal bladder tumors, particularly when intraoperative hemodynamic instability occurs. Early recognition is essential to prevent perioperative complications.

Introduction

Pheochromocytomas are tumors arising from chromaffin cells of the adrenal medulla, while approximately 10% occur in extra-adrenal locations and are termed paragangliomas. Paragangliomas of the urinary bladder are extremely rare, accounting for less than 0.05% of all bladder tumors and approximately 6–10% of extra-adrenal pheochromocytomas. Clinical manifestations are variable and may include hypertension, headache, palpitations, and hematuria. Functional tumors may cause catecholamine-related symptoms, especially during micturition. Here, we present a case of bladder paraganglioma initially misdiagnosed as urothelial carcinoma, with intraoperative hypertensive crisis during surgical resection.

Case Presentation

A 59-year-old man with a history of hypertension and hyperlipidemia under medical treatment presented with intermittent painless hematuria for one month. Physical examination was unremarkable. Urinalysis revealed numerous red blood cells, and urine culture was negative. Contrast-enhanced abdominal computed tomography (CT) demonstrated a 1.4 cm enhancing mass located on the right inferior wall of the urinary bladder. Cystoscopic examination revealed a submucosal tumor over the right lateral wall. With a presumptive diagnosis of urothelial carcinoma, the patient underwent transurethral resection of bladder tumor (TURBT). During the procedure, a sudden elevation in blood pressure exceeding 190 mmHg was noted, raising suspicion of a catecholamine-secreting tumor. The operation was completed without further complications, and the postoperative course was uneventful.

Histopathological examination demonstrated a characteristic Zellballen pattern. Immunohistochemical staining showed strong positivity for synaptophysin and chromogranin, confirming the diagnosis of bladder paraganglioma. The tumor was classified as pT2 based on invasion into the muscularis propria.

Discussion

Bladder paraganglioma is a rare neuroendocrine tumor arising from chromaffin cells within the bladder wall. It accounts for approximately 0.05–0.06% of all bladder tumors and about 6% of extra-adrenal pheochromocytomas. It is more commonly reported in women and typically occurs in patients aged 40–50 years. The urinary bladder is the most common site of genitourinary paragangliomas, comprising approximately 79% of cases. Other sites include the urethra, renal pelvis, and ureter. Clinical presentation varies widely. Up to 80% of patients may exhibit functional symptoms related to catecholamine secretion, including hypertension, palpitations, headache, and micturition syncope. However, nonfunctional tumors may present solely with painless hematuria, as in our case, making preoperative diagnosis challenging. Cystoscopic findings typically reveal a submucosal mass, which can be misdiagnosed as urothelial carcinoma. Intraoperative hypertensive crisis should raise suspicion for paraganglioma. Surgical resection remains the mainstay of treatment. Partial cystectomy is generally preferred over TURBT due to the frequent involvement of the detrusor muscle. The reported local recurrence rate is approximately 10–20%, and 10–15% of tumors may exhibit malignant behavior with metastasis. Given the potential for recurrence and metastasis, long-term follow-up is recommended.

Conclusion

Bladder paraganglioma is a rare entity that may mimic urothelial carcinoma, particularly when presenting as a submucosal bladder mass. This case highlights the importance of considering paraganglioma in the differential diagnosis of bladder tumors, especially when unexplained intraoperative hypertension occurs. Early recognition is crucial to prevent perioperative complications associated with catecholamine release. Complete surgical excision remains the cornerstone of treatment, and long-term surveillance is essential due to the risk of recurrence and potential malignant behavior.

    位置
    資料夾名稱
    摘要
    上傳者
    TUA助理
    單位
    台灣泌尿科醫學會
    建立
    2026-07-01 15:10:39
    最近修訂
    2026-07-01 15:21:38
    1. 1.
      Podium 01
    2. 2.
      Podium 02
    3. 3.
      Podium 03
    4. 4.
      Podium 04
    5. 5.
      Podium 05
    6. 6.
      Podium 06
    7. 7.
      Podium 07
    8. 8.
      Podium 08
    9. 9.
      Podium 09
    10. 10.
      Moderated Poster 01
    11. 11.
      Moderated Poster 02
    12. 12.
      Moderated Poster 03
    13. 13.
      Moderated Poster 04
    14. 14.
      Moderated Poster 05
    15. 15.
      非討論式海報